Baker Bros discloses updated portfolio positions in 13F filing: New positions in NVAX, NLNK, OVID; closed positions in ACOR, DERM
Highlights from 2017 Q2 filing as compared to 2017 Q1 filing:
- New positions in: NVAX (~2 mln shares), NLNK (~0.5 mln), OVID (~0.33 mln), ALBO (~0.2 mln), TENX (~0.13 mln), ARGX (~0.1 mln)
- Increased positions in: ALXN (to ~8.55 mln shares from ~6.54 mln shares), BMRN (to ~5.91 mln from ~4.81 mln), AGLE (to ~1.14 mln from ~0.19 mln), ASND (to ~1.75 mln from ~1.35 mln), SYRS (to ~0.57 mln from ~0.2 mln) RXDX (to ~0.9 mln from ~0.57 mln), BPMX (to ~0.6 mln from ~0.38 mln) HALO (to ~1.58 mln from ~1.39 mln),
- Maintained positions in: SGEN (~45.73 mln shares), INCY (~34.13 mln shares), ACAD (~25.82 mln shares), GHDX (~13.78 mln shares)
- Closed positions in: ACOR (from ~3.3 mln shares), DERM (from ~0.42 mln), BIIB (from ~0.02 mln)
- Decreased positions in: CERS (to ~10.24 mln shares from ~13.05 mln shares), EXEL (to ~2.08 mln from ~2.6 mln), NBIX (to ~0.62 mln from ~0.9 mln), ZGNX (to ~0.19 mln from ~0.38 mln), BLUE (to ~0.3 mln from ~0.35 mln), ANAB (to ~0.12 mln from ~0.15 mln), RARE (to ~0.03 mln from ~0.05 mln)